LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY AS CONDITIONING REGIMENT FOLLOW BY ALLOGENEIC STEM CELL TRANSPLANTATION FOR THE TREATMENT OF ADVANCED AML/MDS PATIENTS

被引：0
|
作者：
Shi, X. [1 ]
Ge, L. [1 ]
Sun, A. [1 ]
Zhu, X. [1 ]
Qiu, H. [1 ]
Jin, Z. [1 ]
Miao, M. [1 ]
Fu, C. [1 ]
Ma, X. [1 ]
Chen, F. [1 ]
Xue, S. [1 ]
Han, Y. [1 ]
Xue, M. [1 ]
Tang, X. [1 ]
Wu, D. [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P355
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [41] Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Heuser, Michael
    Koenecke, Christian
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Panagiota, Victoria
    Klesse, Sabrina
    Stadler, Michael
    Krauter, Juergen
    Dammann, Elke
    Wichmann, Martin
    Shahswar, Rabia
    Bhuju, Sabin
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kleine, Moritz
    Brauns, Wiebke
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Ganser, Arnold
    Kroeger, Nicolaus
    Thol, Felicitas
    BLOOD, 2015, 126 (23)
  • [42] Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation
    Haiwen Huang
    Lihong Zhang
    Yibin Jiang
    Shuo Liu
    Zhengming Jin
    Jia Chen
    Xiaofang Xiao
    Jia Ruan
    Xinyou Zhang
    Depei Wu
    Annals of Hematology, 2019, 98 : 1259 - 1266
  • [43] Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation
    Huang, Haiwen
    Zhang, Lihong
    Jiang, Yibin
    Liu, Shuo
    Jin, Zhengming
    Chen, Jia
    Xiao, Xiaofang
    Ruan, Jia
    Zhang, Xinyou
    Wu, Depei
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1259 - 1266
  • [44] Allogeneic hemopoietic stem cell transplantation (BMT) after IV busulfan, and cyclophosphamide (BuCy) for acute myeloid leukemia (AML) and myelodysplasia (MDS).
    Andersson, BS
    Cagnoni, P
    Jones, R
    Gian, V
    Wingard, JR
    Tarantolo, S
    Kashyap, A
    Forman, SJ
    Hu, WH
    Blume, KG
    Fernandez, HF
    Champlin, RE
    BLOOD, 1999, 94 (10) : 167A - 167A
  • [45] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
    A Shimoni
    I Hardan
    N Shem-Tov
    M Yeshurun
    R Yerushalmi
    A Avigdor
    I Ben-Bassat
    A Nagler
    Leukemia, 2006, 20 : 322 - 328
  • [46] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced intensity conditioning: The role of dose-intensity.
    Shimoni, A
    Hardan, I
    Shem-Tov, N
    Yeshurun, M
    Yerushalmi, R
    Ben-Bassat, I
    Nagler, A
    BLOOD, 2005, 106 (11) : 18A - 19A
  • [47] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity
    Shimoni, A
    Hardan, I
    Shem-Tov, N
    Yeshurun, M
    Yerushalmi, R
    Avigdor, A
    Ben-Bassat, I
    Nagler, A
    LEUKEMIA, 2006, 20 (02) : 322 - 328
  • [48] Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)
    Andersson, BS
    Gajewski, J
    Donato, M
    Giralt, S
    Gian, V
    Wingard, J
    Tarantolo, S
    Fernandez, H
    Hu, WW
    Blume, K
    Kashyap, A
    Forman, SJ
    Champlin, RE
    BONE MARROW TRANSPLANTATION, 2000, 25 (Suppl 2) : S35 - S38
  • [49] Low-dose decitabine as maintenance after allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia
    Bucalossi, Alessandro
    Tozzi, Monica
    Lenoci, Mariapia
    Toraldo, Francesca
    Del Re, Valeria
    Marotta, Giuseppe
    BONE MARROW TRANSPLANTATION, 2019, 54 : 170 - 170
  • [50] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    BLOOD, 2003, 102 (11) : 708A - 708A
12345